Skip to content

Beat the pain in Sickle Cell Disease

Beat the pain in Sickle Cell Disease - BEATS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON55175
Enrollment
100
Registered
2020-07-16
Start date
2025-11-25
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sickle cell disease sickle cell disease

Interventions

N.A.

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
2 Years to 64 Years

Inclusion criteria

Inclusion criteria: • Medical diagnosis of sickle cell disease • Age from 16 years old • Written informed consent.

Exclusion criteria

Exclusion criteria: - Refused informed consent - For heart rate based measurements: medical history of arrhythmias and chronic use of medication affecting the heart rate

Design outcomes

Primary

MeasureTime frame
Primary study parameters: - Heart related variables: resting heart rate, heartrate/steps-ratio - Variables of Heart Rate variability (e.g. Standard deviation of the R-Rintervals = SDNN, RMDD, HF, LF/HF-ratio) Primary oucomes: A: Occurrence of Acute Chest Syndrome B: Self-reported painful crises

Secondary

MeasureTime frame
• Length of stay (LOS) • Need of (P)ICU admission • Need of red blood cell transfusion • Need of analgesic or opioids: maximum dose during hospital admission

Countries

Netherlands

Contacts

Public ContactC.J. Fijnvandraat

Amsterdam UMC

beats@amsterdamumc.nl020-5669111

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)